A Phase III Prospective Randomized, Double-Blind, Placebo-Controlled Trial of the Epidermal Growth Factor Receptor Antagonist, ZD1839 (IRESSA) in Completely Resected Primary Stage IB, II and IIIA Non-Small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT00049543

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:35:47.002156+00:00

Published At

2015-01-01T00:00:00+00:00

Record Updated At

2015-01-01

Results Posted At

2015-01-01

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Adenocarcinoma of the Lung", "Adenosquamous Cell Lung Cancer", "Bronchoalveolar Cell Lung Cancer", "Large Cell Lung Cancer", "Squamous Cell Lung Cancer", "Stage IB Non-small Cell Lung Cancer", "Stage IIA Non-small Cell Lung Cancer", "Stage IIB Non-small Cell Lung Cancer", "Stage IIIA Non-small Cell Lung Cancer"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2015-01-01"

protocolSection.identificationModule.nctId

"NCT00049543"

protocolSection.identificationModule.officialTitle

"A Phase III Prospective Randomized, Double-Blind, Placebo-Controlled Trial of the Epidermal Growth Factor Receptor Antagonist, ZD1839 (IRESSA) in Completely Resected Primary Stage IB, II and IIIA Non-Small Cell Lung Cancer"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2015-01-01"

Study condition terms

• Adenocarcinoma of the Lung (protocolSection.conditionsModule.conditions)
• Adenosquamous Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Bronchoalveolar Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Large Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Squamous Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Stage IB Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Stage IIA Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Stage IIB Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)
• Stage IIIA Non-small Cell Lung Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.